Patent · US Active

Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid

US12358942B2 · kind B2 · utility

0Cited by
49References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2023
Grant dateJul 15, 2025
Priority date
Expiry dateAug 24, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.